COVID-19 IN OLDER ADULTS ANTIBODY RESPONSES OF INACTIVATED SARS-CoV-2 (VERO CELL-SINOVAC) VACCINE FOR ELDERLY COMPARING WITH YOUNGER

Bülent Abut ÖZSEZİKLİ, Simay AKDEMİR, Hatice YILDIZ, Hande SAVAŞAN AKTAY, Zafer ÖZOK

Abstract: Background: Nowadays, researches are being done along with the ongoing vaccination process worldwild. Although the Covid-19 mostly affected the elderly, evidence based studies about the effectiveness and reliability of the vaccine in geriatric population older than 65, is insufficient. So this unique scientific review, aimed to evaluate the Sinovac vaccine outcomes.

Methods: The two doses of the inactivated SARS-CoV-2 (Vero Cell-SINOVAC) vaccine was applied to lodgers and staff. 3 weeks after each dosage, the blood samples were taken from participants to evaluate antibody formation ratios. The outcomes between the lodger and staff groups were compared for vaccine effectiveness at different age groups.

Results: Datas from 34 lodgers with the average age of 78.85±12.56 and from 39 staff with the average age of 48.37±11.37 were taken. In lodgers, 61.8% efficiency of SARS-CoV-2 vaccine with first dose, is increased to 85.3% after the second dose. The increased antibody ratios in the lodgers group is found statistically significant (p<0.05).In staff, 69.2% efficiency of SARS-CoV-2 vaccine with first dose is increased to 97.4% after the second dose. This improved antibody formation between doses was statistically significant within staff group. Also statistically significant difference at the antibody scores between two doses of vaccination in both groups is seen.

Conclusion: According to the age related results with the young staff presented with higher scores compared to elderly lodgers, in our Barınyurt Nursing Home conducted research study, the SARS-CoV-2 (SINOVAC) vaccine is found 91.8% beneficial with the positive antibody score in 67 individuals.

Keywords: Covid-19, Pandemic, Sinovac vaccine, Geriatric population, Nursing home, Antibody score.

Title: COVID-19 IN OLDER ADULTS ANTIBODY RESPONSES OF INACTIVATED SARS-CoV-2 (VERO CELL-SINOVAC) VACCINE FOR ELDERLY COMPARING WITH YOUNGER

Author: Bülent Abut ÖZSEZİKLİ, Simay AKDEMİR, Hatice YILDIZ, Hande SAVAŞAN AKTAY, Zafer ÖZOK

International Journal of Healthcare Sciences

ISSN 2348-5728 (Online)

Research Publish Journals

Vol. 9, Issue 1, April 2021 - September 2021

Citation
Share : Facebook Twitter Linked In

Citation
COVID-19 IN OLDER ADULTS ANTIBODY RESPONSES OF INACTIVATED SARS-CoV-2 (VERO CELL-SINOVAC) VACCINE FOR ELDERLY COMPARING WITH YOUNGER by Bülent Abut ÖZSEZİKLİ, Simay AKDEMİR, Hatice YILDIZ, Hande SAVAŞAN AKTAY, Zafer ÖZOK